Clinical Trials Directory

Trials / Completed

CompletedNCT01205750

Hepatic Insulin Sensitivity and Very Low Density Lipoprotein Triglyceride (VLDL-TG) Kinetics

Basal and Insulin Mediated VLDL-triglyceride Kinetics in Obesity; Relationship With Hepatic Insulin Sensitivity

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
University of Aarhus · Academic / Other
Sex
Male
Age
20 Years – 50 Years
Healthy volunteers
Accepted

Summary

Obesity is associated with dyslipidemia, which is a major risk factor for coronary heart disease. Triglycerides (TG) and cholesterol are transported in the system of lipoproteins, and the metabolism of these lipids in plasma is closely interrelated. Evidence suggests that increased concentration of very low-density lipoprotein triglyceride (VLDL-TG) is a central pathophysiological feature of the lipid and lipoprotein abnormalities in dyslipidemia. The primary objective of this study is to investigate VLDL-TG kinetics and hepatic insulin sensitivity in age-matched obese and lean, healthy men in the postabsorptive state and during acute hyperinsulinemia using VLDL-TG and glucose tracers.

Detailed description

Extensive description not included.

Conditions

Interventions

TypeNameDescription
OTHERGlucose clamp450 min hyperinsulinemic euglycemic glucose clamp, 0,5 mU / kg lean body mass / min

Timeline

Start date
2010-03-01
Primary completion
2010-09-01
Completion
2010-09-01
First posted
2010-09-20
Last updated
2011-06-17

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT01205750. Inclusion in this directory is not an endorsement.